Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 104 Thousand ILS | -71.89% |
| 2022 | 370 Thousand ILS | -96.55% |
| 2021 | 10.72 Million ILS | 72.4% |
| 2020 | 6.21 Million ILS | -88.77% |
| 2019 | 55.39 Million ILS | 1246.16% |
| 2018 | -4.83 Million ILS | -143.82% |
| 2017 | 11.02 Million ILS | 148.4% |
| 2016 | -22.78 Million ILS | -32.99% |
| 2015 | -17.13 Million ILS | 96.61% |
| 2014 | -505.26 Million ILS | -25705.06% |
| 2013 | -1.95 Million ILS | -125.52% |
| 2012 | 7.67 Million ILS | -15.4% |
| 2011 | 9.06 Million ILS | 155.77% |
| 2010 | 3.54 Million ILS | -18.75% |
| 2009 | 4.36 Million ILS | 53.79% |
| 2008 | 2.83 Million ILS | 111.87% |
| 2007 | 1.33 Million ILS | -35.06% |
| 2006 | 2.06 Million ILS | 46.87% |
| 2005 | 1.4 Million ILS | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 36 Thousand ILS | -28.0% |
| 2023 Q4 | 16 Thousand ILS | 0.0% |
| 2023 Q2 | 36 Thousand ILS | 0.0% |
| 2023 Q3 | 16 Thousand ILS | -55.56% |
| 2023 FY | 104 Thousand ILS | -71.89% |
| 2022 Q2 | -857 Thousand ILS | -373.8% |
| 2022 Q3 | 239 Thousand ILS | 127.89% |
| 2022 FY | 370 Thousand ILS | -96.55% |
| 2022 Q4 | 50 Thousand ILS | -79.08% |
| 2022 Q1 | 313 Thousand ILS | -41.39% |
| 2021 Q2 | 3.03 Million ILS | -16.53% |
| 2021 FY | 10.72 Million ILS | 72.4% |
| 2021 Q4 | 534 Thousand ILS | -84.86% |
| 2021 Q3 | 3.52 Million ILS | 16.37% |
| 2021 Q1 | 3.63 Million ILS | 61.76% |
| 2020 Q4 | 2.24 Million ILS | -56.09% |
| 2020 FY | 6.21 Million ILS | -88.77% |
| 2020 Q1 | -627 Thousand ILS | -157.31% |
| 2020 Q2 | -509 Thousand ILS | 18.82% |
| 2020 Q3 | 5.11 Million ILS | 1103.93% |
| 2019 Q4 | 1.09 Million ILS | 142.7% |
| 2019 Q2 | 59.19 Million ILS | 2639.38% |
| 2019 FY | 55.39 Million ILS | 1246.16% |
| 2019 Q1 | -2.33 Million ILS | -141.55% |
| 2019 Q3 | -2.56 Million ILS | -104.33% |
| 2018 Q3 | -939 Thousand ILS | 26.3% |
| 2018 Q1 | 928 Thousand ILS | 116.42% |
| 2018 FY | -4.83 Million ILS | -143.82% |
| 2018 Q4 | -965 Thousand ILS | -2.77% |
| 2018 Q2 | -1.27 Million ILS | -237.28% |
| 2017 Q4 | -5.65 Million ILS | -124.36% |
| 2017 Q2 | -4.9 Million ILS | -203.72% |
| 2017 Q1 | -1.61 Million ILS | 79.93% |
| 2017 FY | 11.02 Million ILS | 148.4% |
| 2017 Q3 | 23.19 Million ILS | 573.17% |
| 2016 Q2 | -4.16 Million ILS | 39.95% |
| 2016 Q1 | -6.92 Million ILS | 19.34% |
| 2016 Q3 | -3.65 Million ILS | 12.16% |
| 2016 FY | -22.78 Million ILS | -32.99% |
| 2016 Q4 | -8.04 Million ILS | -120.09% |
| 2015 Q3 | -3.2 Million ILS | 57.09% |
| 2015 FY | -17.13 Million ILS | 96.61% |
| 2015 Q2 | -7.45 Million ILS | -452.74% |
| 2015 Q4 | -8.58 Million ILS | -168.41% |
| 2015 Q1 | 2.11 Million ILS | 100.42% |
| 2014 Q2 | -2.27 Million ILS | -622.54% |
| 2014 Q1 | -315 Thousand ILS | -288.89% |
| 2014 FY | -505.26 Million ILS | -25705.06% |
| 2014 Q4 | -501.01 Million ILS | -30063.21% |
| 2014 Q3 | -1.66 Million ILS | 27.02% |
| 2013 Q2 | 1.16 Million ILS | 13033.33% |
| 2013 Q3 | -1.67 Million ILS | -243.56% |
| 2013 FY | -1.95 Million ILS | -125.52% |
| 2013 Q4 | -81 Thousand ILS | 95.15% |
| 2013 Q1 | -9000.00 ILS | -100.39% |
| 2012 Q3 | 2.25 Million ILS | 17.67% |
| 2012 Q4 | 2.32 Million ILS | 3.01% |
| 2012 FY | 7.67 Million ILS | -15.4% |
| 2012 Q1 | 1.17 Million ILS | 0.0% |
| 2012 Q2 | 1.91 Million ILS | 63.79% |
| 2011 FY | 9.06 Million ILS | 155.77% |
| 2010 FY | 3.54 Million ILS | -18.75% |
| 2009 FY | 4.36 Million ILS | 53.79% |
| 2008 FY | 2.83 Million ILS | 111.87% |
| 2007 FY | 1.33 Million ILS | -35.06% |
| 2006 FY | 2.06 Million ILS | 46.87% |
| 2005 FY | 1.4 Million ILS | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Matricelf Ltd | -811 Thousand ILA | 112.824% |